Laura Pat Svetkey, MD

Professor of Medicine
Director of Clinical Research
Vice-chair for Faculty Development & Diversity in the Department of Medicine
Campus mail Duke Box 3487, Durham, NC 27710
Phone (919) 660-6626
Email address svetk001@mc.duke.edu

Laura P. Svetkey, MD MHS is Professor of Medicine, Director of the Duke Hypertension Center, Director of Clinical Research at the Sarah W. Stedman Nutrition and Metabolism Center, Vice Chair for Faculty Development and Diversity in the Department of Medicine. She is also the Director of Duke’s CTSA internal career development award program (KL2).She is a faculty member of the Duke Molecular Physiology Institute (DMPI) and the Cardiovascular Research Center (CVRC). She is co-Director of the Clinical and Translational Core of the Duke O’Brien Center for Kidney Research (DOCK).

Dr. Svetkey has over 30 years of experience in the investigation of hypertension, obesity, and related areas, conducting NIH-sponsored clinical research ranging from behavioral intervention trials to metabolomics and genetics, with a consistent focus on prevention, non-pharmacologic intervention, health disparities and minority health. Her research has affected national guidelines, having served on the 2013 national Hypertension Guideline Panel (JNC) and the Lifestyle Guideline Working Group. She is a member of the Association of American Physicians (AAP).

Dr. Svetkey is Vice Chair for Faculty Development and Diversity in the Department of Medicine.  In this role she implements a wide range of programs to enhance the experience and advancement of faculty and trainees, with particular emphasis on under-represented minorities and women.

Education and Training

  • Fellow in General Internal Medicine, Medicine, Duke University, 1982 - 1983
  • Resident in Medicine, Medicine, Montefiore Medical Center, 1980 - 1982
  • Intern in Medicine, Medicine, Montefiore Medical Center, 1979 - 1980
  • M.D., Harvard University, 1979

Publications

Patel, MJ, Batch, BC, Svetkey, LP, Bain, JR, Turer, CB, Haynes, C, Muehlbauer, MJ, Stevens, RD, Newgard, CB, and Shah, SH. "Race and sex differences in small-molecule metabolites and metabolic hormones in overweight and obese adults." OMICS 17, no. 12 (December 2013): 627-635.

PMID
24117402
Full Text

Chang, A, Batch, BC, McGuire, HL, Vollmer, WM, Svetkey, LP, Tyson, CC, Sanguankeo, A, Anderson, C, Houston, J, and Appel, LJ. "Association of a reduction in central obesity and phosphorus intake with changes in urinary albumin excretion: The PREMIER study." American Journal of Kidney Diseases 62, no. 5 (November 1, 2013): 900-907.

Full Text

Chang, A, Batch, BC, McGuire, HL, Vollmer, WM, Svetkey, LP, Tyson, CC, Sanguankeo, A, Anderson, C, Houston, J, and Appel, LJ. "Association of a reduction in central obesity and phosphorus intake with changes in urinary albumin excretion: the PREMIER study." Am J Kidney Dis 62, no. 5 (November 2013): 900-907.

PMID
23810691
Full Text

Lin, P-H, Yancy, WS, Pollak, KI, Dolor, RJ, Marcello, J, Samsa, GP, Batch, BC, and Svetkey, LP. "The influence of a physician and patient intervention program on dietary intake." J Acad Nutr Diet 113, no. 11 (November 2013): 1465-1475.

PMID
23999279
Full Text

Lin, PH, Batch, BC, and Svetkey, LP. "Nutrition, Lifestyle, and Hypertension." (August 29, 2013): 569-595. (Chapter)

Full Text

Batch, BC, Shah, SH, Newgard, CB, Turer, CB, Haynes, C, Bain, JR, Muehlbauer, M, Patel, MJ, Stevens, RD, Appel, LJ, Newby, LK, and Svetkey, LP. "Branched chain amino acids are novel biomarkers for discrimination of metabolic wellness." Metabolism 62, no. 7 (July 2013): 961-969.

PMID
23375209
Full Text

Corsino, L, Lin, P-H, Batch, BC, Intille, S, Grambow, SC, Bosworth, HB, Bennett, GG, Tyson, C, Svetkey, LP, and Voils, CI. "Recruiting young adults into a weight loss trial: report of protocol development and recruitment results." Contemp Clin Trials 35, no. 2 (July 2013): 1-7.

PMID
23591327
Full Text

Chatterjee, R, Thomas, L, Svetkey, L, Brancati, FL, Califf, RM, and Edelman, D. "Effects of changes in potassium with valsartan use on diabetes risk: Nateglinide and Valsartan in Impaired Glucose Tolerance Outcomes Research (NAVIGATOR) trial." Am J Hypertens 26, no. 6 (June 2013): 723-726.

PMID
23417031
Full Text

Batch, BC, Ard, JD, Vollmer, WM, Funk, K, Appel, LJ, Stevens, VJ, Samuel-Hodge, C, Loria, CM, Hollis, JF, and Svetkey, LP. "Impact of participant and interventionist race concordance on weight loss outcomes." Obesity (Silver Spring) 21, no. 4 (April 2013): 712-717.

PMID
23712973
Full Text

Haga, SB, Barry, WT, Mills, R, Ginsburg, GS, Svetkey, L, Sullivan, J, and Willard, HF. "Public knowledge of and attitudes toward genetics and genetic testing." Genet Test Mol Biomarkers 17, no. 4 (April 2013): 327-335.

PMID
23406207
Full Text

Pages